Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.44 |
| ▸ | HTR2B | P41595 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7684984 | 0.84 | CHRNA7 (0.41) | TAAR1CHRNA7OPRM1OPRD1OPRK1 | |
| SCHEMBL3841615 | 0.81 | HTR2C (0.53) | HTR2CHTR2B | |
| SCHEMBL7560367 | 0.81 | CHRNA7 (0.65) | HTR2CHTR2BTAAR1CHRNA7OPRM1 | |
| SCHEMBL6002146 | 0.81 | HTR1A (0.45) | HTR2C | |
| SCHEMBL7526106 | 0.81 | CHRNA7 (0.65) | HTR2CHTR2BTAAR1CHRNA7OPRM1 | |
| SCHEMBL7832435 | 0.81 | CHRNA7 (0.65) | HTR2CHTR2BTAAR1CHRNA7OPRM1 | |
| SCHEMBL7563225 | 0.81 | CHRNA7 (0.65) | HTR2CHTR2BTAAR1CHRNA7OPRM1 | |
| SCHEMBL7684611 | 0.80 | HTR1A (0.43) | HTR2CCHRNA7 | |
| SCHEMBL6001682 | 0.77 | RAD52 (0.43) | HTR2C | |
| SCHEMBL31204632 | 0.76 | CHRNA7 (0.66) | HTR2CTAAR1CHRNA7OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6417183-B1 | DRUGS RELATES TO 1,4-DIAZACYCLOHEPTANES, TO PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND TO THEIR USE IN METHODS OF THERAPEUTIC TREATMENT OF NERVOUS SYSTEM DISORDERS | ASTRAZENELA UK LIMITED (GB) | 2002-07-09 | — | — | US | disclosed |
| EP-1060169-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES | AstraZeneca AB (SE) | 2000-12-20 | — | — | EP | disclosed |
| WO-1999032461-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES | ASTRAZENECA UK LIMITED (GB) | 1999-07-01 | — | — | WO | disclosed |